Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial

BACKGROUND: Obesity is a growing health problem leading to high rates of mortality and morbidity in patients with severe mental illness (SMI). The increased rate of obesity is largely attributed to antipsychotic use. The effect of antipsychotic medications on H1 and 5HT2 receptors has been associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tek, Cenk, Guloksuz, Sinan, Srihari, Vinod H, Reutenauer, Erin L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702521/
https://www.ncbi.nlm.nih.gov/pubmed/23805859
http://dx.doi.org/10.1186/1471-244X-13-176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702521/
https://www.ncbi.nlm.nih.gov/pubmed/23805859
http://dx.doi.org/10.1186/1471-244X-13-176

Ejemplares similares